Buy Dr. Lal Pathlabs, target price Rs 2820: BNP Paribas Securities
Promoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
By ETMarkets.com |
BCCL
BNP Paribas Securities has buy call on Dr. Lal Pathlabs with a target price of Rs 2820.The current market price of Dr. Lal Pathlabs is Rs 2154.35.
Dr. Lal Pathlabs, incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 17999.42 Crore) operating in Hospitals & Allied Services sector.
Dr. Lal Pathlabs key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 542.50 Crore, up 6.16 % from last quarter Total Income of Rs 511.00 Crore and up 5.81 % from last year same quarter Total Income of Rs 512.70 Crore. Company has reported net profit after tax of Rs 72.40 Crore in latest quarter.
The company’s top management includes Brig.(Hony) Dr.Arvind Lal, Mrs.Somya Satsangi, Dr.Saurabh Srivastava, Mr.Harneet Singh Chandhoke, Mr.Sunil Varma, Mr.Anoop Mahendra Singh, Mr.Rahul Sharma, Dr.Vandana Lal, Dr.Om Prakash Manchanda, Dr.Archana Lal Erdmann. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2022, the company has a total of 8 Crore shares outstanding.
Promoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
Dr. Lal Pathlabs, incorporated in the year 1995, is a Mid Cap company (having a market cap of Rs 17999.42 Crore) operating in Hospitals & Allied Services sector.
Dr. Lal Pathlabs key Products/Revenue Segments include Hospital Services and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-09-2022, the company has reported a Consolidated Total Income of Rs 542.50 Crore, up 6.16 % from last quarter Total Income of Rs 511.00 Crore and up 5.81 % from last year same quarter Total Income of Rs 512.70 Crore. Company has reported net profit after tax of Rs 72.40 Crore in latest quarter.
The company’s top management includes Brig.(Hony) Dr.Arvind Lal, Mrs.Somya Satsangi, Dr.Saurabh Srivastava, Mr.Harneet Singh Chandhoke, Mr.Sunil Varma, Mr.Anoop Mahendra Singh, Mr.Rahul Sharma, Dr.Vandana Lal, Dr.Om Prakash Manchanda, Dr.Archana Lal Erdmann. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-09-2022, the company has a total of 8 Crore shares outstanding.
ADVERTISEMENT
Promoter/FII Holdings Promoters held 55.05 per cent stake in the company as of 30-Sep-2022, while FIIs owned 22.37 per cent, DIIs 6.27 per cent.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
